Textron Total Cost of Revenue decreased by 6.5% to $2.49B in Q3 2021 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | |
|---|---|---|---|
| Value | $2.40B | $2.66B | $2.49B |
| QoQ Change | — | +10.8% | -6.5% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Textron Aviation | — | — | — | — | — | — | — | $1.15B |
| Bell | — | — | — | — | — | — | — | $904.00M |
| Industrial | — | — | — | — | — | — | — | $661.00M |
| Textron Systems | — | — | — | — | — | — | — | $258.00M |
| Finance | — | — | — | — | — | — | — | $0.00 |
| Textron eAviation | $9.00M | $5.00M | $9.00M | $6.00M | $7.00M | $7.00M | $7.00M | — |
| Total | — | — | — | — | — | — | — | — |
Textron eAviation was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.